Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/35451
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Trevillyan, Janine M | - |
dc.contributor.author | Dart, Anthony | - |
dc.contributor.author | Paul, Eldho | - |
dc.contributor.author | Dewar, Elizabeth M | - |
dc.contributor.author | Hall, Victoria G | - |
dc.contributor.author | Hoy, Jennifer F | - |
dc.date | 2024 | - |
dc.date.accessioned | 2024-09-10T01:43:06Z | - |
dc.date.available | 2024-09-10T01:43:06Z | - |
dc.date.issued | 2024-09-01 | - |
dc.identifier.citation | AIDS (London, England) 2024-09-01; 38(11) | en_US |
dc.identifier.issn | 1473-5571 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/35451 | - |
dc.description.abstract | This single-centre substudy of a double-blind, randomized, placebo-controlled trial aimed to determine the effect of 96 weeks of rosuvastatin on pulse wave velocity (PWV) in men (n = 55, 54 years) with HIV at moderate cardiovascular risk (Framingham risk score 10-15%). PWV increased in both rosuvastatin [0.54 m/s standard error of difference (SED) 0.26] and placebo [0.50 m/s (SED 0.26), P = 0.896] arms, leading to no difference in PWV at week 96 [rosuvastatin 9.40 m/s (SE 0.31); placebo 9.21 m/s (SE0.31), P = 0.676]. | en_US |
dc.language.iso | eng | - |
dc.title | Impact of rosuvastatin on pulse-wave velocity in men with HIV at moderate cardiovascular risk. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | AIDS (London, England) | en_US |
dc.identifier.affiliation | Infectious Diseases | en_US |
dc.identifier.affiliation | Department of Cardiology, Alfred Health. | en_US |
dc.identifier.affiliation | ANZIC-RC, School of Public Health and Preventive Medicine, Monash University. | en_US |
dc.identifier.affiliation | Department of Cardiology, Alfred Health. | en_US |
dc.identifier.affiliation | Department of Infectious Diseases, Peter MacCallum Cancer Centre. | en_US |
dc.identifier.affiliation | Department of Infectious Diseases, Alfred Health and Monash University, Melbourne Australia. | en_US |
dc.identifier.doi | 10.1097/QAD.0000000000003930 | en_US |
dc.type.content | Text | en_US |
dc.identifier.pubmedid | 39088829 | - |
dc.description.volume | 38 | - |
dc.description.issue | 11 | - |
dc.description.startpage | 1722 | - |
dc.description.endpage | 1724 | - |
dc.subject.meshtermssecondary | Rosuvastatin Calcium/therapeutic use | - |
dc.subject.meshtermssecondary | Rosuvastatin Calcium/administration & dosage | - |
dc.subject.meshtermssecondary | HIV Infections/drug therapy | - |
dc.subject.meshtermssecondary | HIV Infections/complications | - |
dc.subject.meshtermssecondary | Placebos/administration & dosage | - |
dc.subject.meshtermssecondary | Sulfonamides/therapeutic use | - |
dc.subject.meshtermssecondary | Sulfonamides/pharmacology | - |
dc.subject.meshtermssecondary | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | - |
dc.subject.meshtermssecondary | Fluorobenzenes/therapeutic use | - |
item.openairetype | Journal Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.fulltext | No Fulltext | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.